Why rigorous clinical evaluations matter: strategies to boost safety and compliance

Published: 2-Apr-2025 Featured companies: NSF
Medical Devices

This white paper provides a blueprint for achieving excellence in clinical evaluations through strategic enhancements

Did you know that 40% of medical device submissions are delayed due to inadequate clinical evaluations? In the highly competitive medical device market, mastering clinical evaluations is not just a regulatory hurdle but a strategic imperative. Effective clinical evaluations can accelerate market entry, enhance brand reputation, and ensure sustained competitive superiority. This white paper provides a blueprint for achieving excellence in clinical evaluations through strategic enhancements. Through real-world case studies and actionable insights, discover how to achieve excellence and maintain a competitive edge in the medical device market.

Click here to find out why rigorous clinical evaluations matter

Featured companies

Founded in 1944, NSF’s mission is to protect and improve global human health. NSF, Pharmaceutical Services provides a comprehensive range of independent, third-party...
See more

You may also like

Regulatory

NSF launches new IVD app

Read more
This free app is full of useful resources, perfect for any IVD professional on the go

Trending Articles

  1. embecta completes £100m acquisition of UK-based Owen Mumford to bolster drug delivery portfolio US diabetes care company embecta has finalised its acquisition of Owen Mumford, gaining access to the Aidaptus next-generation auto-injector platform as it accelerates its transition into a broad-based medical supplies company
  2. Quibim appoints Itta MacNevin as Chief Business Officer to accelerate global growth and life sciences partnerships Quibim, the global pioneer in imaging biomarkers for precision medicine, is pleased to announce the appointment of Itta MacNevin as Chief Business Officer (CBO). The appointment marks a significant step in Quibim’s strategy to scale its commercial operations, deepen partnerships across life sciences, and accelerate adoption of its AI-powered imaging solutions globally
  3. BSI publishes revised ISO 10993-1:2025 standard to strengthen medical device biocompatibility assessment BSI has released a revised edition of BS EN ISO 10993-1, updating the internationally recognised framework for evaluating the biological safety of medical devices in line with advances in material science, toxicology and risk management
  4. Owlstone Medical appoints Dr Andy Richards to board
  5. You need to be a subscriber to read this article.
    Click here to find out more.
    Autoinjector development The autoinjector is one of the fastest emerging drug delivery solutions. It consists of a pre-filled syringe or cartridge inside a device that applies enough force to inject fully the desired drug within the specified requirements. Insufficient planning and early conceptual design vulnerabilities can result in quality issues, prolonged project timeline and increased cost. A device manufacturing partner will therefore need basic mechanical device knowledge and regulatory experience.

Relevant companies

See more

Upcoming event

CHEMUK 2026

20–21 May 2026 | Conference and Exhibition | Birmingham, UK See all

You may also like

Regulatory

NSF launches new IVD app

This free app is full of useful resources, perfect for any IVD professional on the go
Manufacturing

Time to move beyond mediocre CAPAs and make them more effective

Andy Barnett, NSF, presents a white paper on CAPAs and how to make them more effective
Training & Education

Management Forum and NSF-DBA team up

To provide certification programmes to demonstrate medical device competence
Drug Delivery

embecta completes £100m acquisition of UK-based Owen Mumford to bolster drug delivery portfolio

US diabetes care company embecta has finalised its acquisition of Owen Mumford, gaining access to the Aidaptus next-generation auto-injector platform as it accelerates its transition into a broad-based medical supplies company
Manufacturing

Nemera partners with Therakind to expand nasal drug delivery portfolio with DriDose dry powder platform

The manufacturer has announced a strategic partnership with UK pharmaceutical company Therakind to advance the DriDose intranasal dry powder platform, adding dry powder delivery capabilities to complement Nemera's existing liquid nasal formulation offering
Medical Devices

Titan Enterprises advances non-intrusive flow measurement for medical applications

Titan Enterprises is developing a small-bore clamp-on ultrasonic flowmeter designed specifically for medical and life-science applications
Medical Devices

Merck and Calla Lily Clinical Care team up to improve intravaginal drug delivery solution

The collaboration aims to support the continued development of a new self-administered solution for vaginal therapeutics to address unmet needs in women’s health
Subscribe now